Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-09

Clinical Trial Update: Impact of Combined Medication and Behavioral Treatment for ASD & ADHD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on combined medication and behavioral treatment for autism spectrum disorder and attention-deficit/hyperactivity disorder was terminated;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder | Phase 2 | Status: TERMINATED | Results posted: 2022-03-09